These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1448123)

  • 1. Prevention and treatment of pneumocystis pneumonia.
    Masur H
    N Engl J Med; 1992 Dec; 327(26):1853-60. PubMed ID: 1448123
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy and prevention of pneumocystis carinii pneumonia].
    Goebel FD; Bogner JR
    Internist (Berl); 1995 Dec; 36(12):1150-5. PubMed ID: 8567220
    [No Abstract]   [Full Text] [Related]  

  • 3. [Possibilities of chemoprophylaxis and chemotherapy in protozoan opportunistic infections].
    Ortona L; Antinori A
    G Ital Chemioter; 1991; 38(1-3):83-5. PubMed ID: 1365619
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous pentamidine as an alternate for Pneumocystis carinii pneumonia prophylaxis in children with HIV infection.
    Gupta M; Stephenson K; Gauar S; Frenkel L
    Pediatr Pulmonol Suppl; 1997; 16():199-200. PubMed ID: 9443273
    [No Abstract]   [Full Text] [Related]  

  • 5. Bactrim approved for prophylaxis.
    AIDS Patient Care; 1994 Jun; 8(3):166. PubMed ID: 11362143
    [No Abstract]   [Full Text] [Related]  

  • 6. Does the choice of Pneumocystis carinii prophylaxis influence the prevalence of Enterocytozoon bieneusi microsporidiosis in AIDS patients?
    Albrecht H; Sobottka I; Stellbrink HJ; Greten H
    AIDS; 1995 Mar; 9(3):302-3. PubMed ID: 7755923
    [No Abstract]   [Full Text] [Related]  

  • 7. Polypharmacy: dangers of multiple-drug therapy in patients with immunodeficiency virus infection.
    Ungvarski P; Schmidt J
    Home Healthc Nurse; 1993; 11(2):68-9. PubMed ID: 8478201
    [No Abstract]   [Full Text] [Related]  

  • 8. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
    Chaisson RE; Keruly J; Richman DD; Moore RD
    Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary prophylaxis against opportunistic infections in patients with AIDS.
    Clumeck N
    N Engl J Med; 1995 Mar; 332(11):739-40. PubMed ID: 7854383
    [No Abstract]   [Full Text] [Related]  

  • 10. Prophylaxis and therapy for Pneumocystis pneumonia--where are we?
    Masur H
    Infect Agents Dis; 1992 Oct; 1(5):270-8. PubMed ID: 1344666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New developments in the management of Pneumocystis carinii disease.
    Safrin S
    AIDS Clin Rev; 1993-1994; ():95-112. PubMed ID: 8217906
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention and treatment of Pneumocystis pneumonia.
    Ong EL; Mandal BK
    N Engl J Med; 1993 May; 328(21):1569. PubMed ID: 8479504
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased hyperglycaemia during cotreatment with pentamidine and corticosteroids in AIDS patients.
    Gambini D; Brambilla AM; Galli C; Castagna A; Veglia F; Lazzarin A
    AIDS; 1997 Nov; 11(13):1652-3. PubMed ID: 9365773
    [No Abstract]   [Full Text] [Related]  

  • 14. Pneumocystis carinii pneumonia prophylaxis during pregnancy.
    Connelly RT; Lourwood DL
    Pharmacotherapy; 1994; 14(4):424-9. PubMed ID: 7937279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.
    Bozzette SA; Finkelstein DM; Spector SA; Frame P; Powderly WG; He W; Phillips L; Craven D; van der Horst C; Feinberg J
    N Engl J Med; 1995 Mar; 332(11):693-9. PubMed ID: 7854375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discontinuing prophylaxis against Pneumocystis carinii pneumonia.
    Bender MA; Sax PE
    N Engl J Med; 2001 May; 344(21):1639; author reply 1640-1. PubMed ID: 11374364
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
    Warnock AC; Rimland D
    Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing PCP therapy.
    Torres G; Cadman J
    GMHC Treat Issues; 1997 Oct; 11(10):3-5. PubMed ID: 11364821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021.
    Hardy WD; Feinberg J; Finkelstein DM; Power ME; He W; Kaczka C; Frame PT; Holmes M; Waskin H; Fass RJ
    N Engl J Med; 1992 Dec; 327(26):1842-8. PubMed ID: 1448121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of pneumonia related to HIV--pneumocystis carinii pneumonia (PCP)].
    Sidahora; 1995; ():31-2. PubMed ID: 11363204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.